Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.

Journal of vascular and interventional radiology : JVIR - 1 Jul 2007

Kuo Michael D, Gollub Jeremy, Sirlin Claude B, Ooi Clara, Chen Xin

Abstract excerpt

PURPOSE: To determine whether conventional contrast-enhanced computed tomography (CT) could be used to identify imaging phenotypes associated with a doxorubicin drug response gene expression program in hepatocellular carcinoma (HCC) by using an integrated imaging-genomic approach. MATERIALS AND METHODS: Thirty HCCs were analyzed and scored individually across six predefined imaging phenotypes. Unsupervised and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Contrast Media

Share to Doxorubicin

Share to Least-Squares Analysis

Share to Liver Neoplasms

Share to Microarray Analysis

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 17609439
DOI: 10.1016/j.jvir.2007.04.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.PMID 17609439Read ↗

Radiogenomics of hepatocellular carcinoma: multiregion analysis-based identification of prognostic imaging biomarkers by integrating gene data—a preliminary studySemantic proximity Read ↗

Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profilingSemantic proximity Read ↗

Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.Semantic proximity Read ↗

Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression.Semantic proximity Read ↗

Radiogenomics-based cancer prognosis in colorectal cancerSemantic proximity Read ↗

Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.Semantic proximity Read ↗

Data-Driven Radiogenomic Approach for Deciphering Molecular Mechanisms Underlying Imaging Phenotypes in Lung Adenocarcinoma: A Pilot Study.Semantic proximity Read ↗

Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular CarcinomaSemantic proximity Read ↗

Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.Semantic proximity Read ↗

Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.Semantic proximity Read ↗

Gene Expression Profile Associated with Response to Doxorubicin-Based Therapy in Breast CancerSemantic proximity Read ↗

Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.